Belimumab for Treatment of cGVHD Following Allo-HCT

NCT05604742 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped No patients eligible for inclusion

Conditions

Interventions

Sponsor

xuna